IL13RA2 and central nervous system cancer: A trial by Pollack et al., 2014 used glioma-associated antigen (GAA) vaccine consisting of EphA2, interleukin-13 receptor alpha 2 (IL-13Rα2), and survivin in HLA-A2–positive children with newly diagnosed brainstem glioma and HGG.